NxStage acquired by Fresenius for $2bn

15:40 EDT 8 Aug 2017 | Elsevier Business Intelligence

Fresenius Medical Care AG & Co. KGAA will pay $30 per share (a 27% premium; $1.98bn equity value and $1.93bn enterprise value...

Original Article: NxStage acquired by Fresenius for $2bn


More From BioPortfolio on "NxStage acquired by Fresenius for $2bn"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

In medicine, dialysis is a process for removing waste and excess water from the blood, and is primarily used to provide an artificial replacement for lost kidney function in people with renal failure. Dialysis may be used for those with an acute disturba...